About Shock Analytics


Shock Analytics has developed a non-invasive device for measuring systemic vascular resistance (SVR), an indicator for both congestive heart failure and sepsis, two of the deadliest and most costly diseases in modern medicine. Currently, the gold standard for measuring SVR is a right heart catheterization, a very invasive and costly procedure.
visit | email 

Key People


Jennifer Monti
CEO, CSO


Veena Krish
CTO


Bob Harrington
COO


Bill Bullard
CFO